Pfizer shares fell as much as 3.1% after Dow Jones reported that the company expected to ship half of the Covid-19 vaccines it had originally planned for 2020 because of supply-chain problems. Â© 2020 Bloomberg Subscribe for full access to all our share and unit trust data tools, our award-winning articles, and support quality journalism in the process. You will be redirected to a checkout page.
To view all features and options, click here. A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership.